4.4 Article

Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles

期刊

SURGERY FOR OBESITY AND RELATED DISEASES
卷 9, 期 2, 页码 207-212

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2011.09.026

关键词

Microparticles; Tissue factor; Inflammation; Obesity; Bariatric surgery; Type 2 diabetes mellitus

类别

资金

  1. National Institutes of Health [RO1 DK089547, RO1 AG12834]
  2. Multidisciplinary Clinical Research Career Development Programs [K12 RR023264, P50 HL081011]
  3. Ethicon Endo-Surgery
  4. Stryker Endoscopy
  5. Bard/Davol
  6. Gore
  7. Baxter
  8. Covidien
  9. Allergan
  10. Nestle Int.

向作者/读者索取更多资源

Background: Microparticles bud from cellular elements during inflammation and are associated with the vascular dysfunction related to type 2 diabetes mellitus. Although weight loss is known to reduce inflammation, the metabolic effects of bariatric surgery on microparticle concentration and composition are not known. Our objectives were to determine the effect of bariatric surgery on the microparticle concentration and to correlate these changes with clinical parameters in a multispecialty group practice. Methods: We studied 14 obese subjects with type 2 diabetes mellitus 2 weeks before and 1 and 12 months after bariatric surgery. Of the 14 patients, 9 underwent Roux-en-Y gastric bypass and 5 gastric restrictive surgery. Results: At 1 month after surgery, the body mass index had decreased by similar to 10%, glycemic control had improved dramatically (P < .01), and a >60% reduction in endothelial and platelet microparticles and C-reactive protein levels (P < .05) had occurred. The tissue factor microparticles had decreased by 40% (P = .1). At 12 months after surgery, the body mass index had decreased by similar to 20%, glycemic control was maintained (P < .01), and a >50% reduction in monocyte microparticles compared with before surgery was found. The reduction in monocyte microparticles 1 month after surgery was strongly associated with the reduction in hemoglobin A1c (P < .05). The reduction in monocyte microparticles 12 months after surgery correlated strongly with the reduction in body mass index (P < .05). Conclusion: The reduction in microparticles after bariatric surgery in patients with type 2 diabetes mellitus reflects an attenuation of inflammation, and this mechanism might contribute to normalization of glycemic control. (Surg Obes Relat Dis 2013;9:207-212.) (C) 2013 American Society for Metabolic and Bariatric Surgery. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Endocrinology & Metabolism

Bariatric Surgery: It's Not Just Incretins!

Rafael Ferraz-Bannitz, Sangeeta Kashyap, Mary Elizabeth Patti

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

Matthew C. Riddle, William T. Cefalu, Philip H. Evans, Hertzel C. Gerstein, Michael A. Nauck, William K. Oh, Amy E. Rothberg, Carel W. le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour

Summary: Improvement of glucose levels in people with diabetes can occur spontaneously or after medical interventions. Newer forms of treatment may lead to more sustained improvement. However, the terminology and objective measures for defining this process are not established, and the long-term risks and benefits are not well understood. An international expert group proposed the term "remission" and HbA1c < 6.5% as the usual diagnostic criterion. They also suggested active observation and further research on predictors and outcomes of remission.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes

Neda Rasouli, Irwin G. Brodsky, Ranee Chatterjee, Sun H. Kim, Richard E. Pratley, Myrlene A. Staten, Anastassios G. Pittas

Summary: Supplementation with vitamin D-3 for 24 months did not improve beta-cell function in people with prediabetes, but showed benefits in those with very low baseline vitamin D levels.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Editorial Material Surgery

Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery?

Paulina Salminen, Gerhard Prager, Phil R. Schauer

JAMA SURGERY (2022)

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W. Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Miriam B. Vos, Zobair Younossi

Summary: This article provides evidence-based recommendations for the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) for endocrinologists, primary care clinicians, and other stakeholders. The guideline includes 34 evidence-based clinical practice recommendations and contains relevant citations.

ENDOCRINE PRACTICE (2022)

Article Clinical Neurology

Obesity-associated sleep hypoventilation and increased adverse postoperative bariatric surgery outcomes in a large clinical retrospective cohort

Pornprapa Chindamporn, Lu Wang, James Bena, Alexander Zajichek, Alex Milinovic, Roop Kaw, Sangeeta R. Kashyap, Derrick Cetin, Ali Aminian, Nancy Kempke, Nancy Foldvary-Schaefer, Loutfi S. Aboussouan, Reena Mehra

Summary: By analyzing a clinical cohort, this study found that patients with obesity-associated sleep hypoventilation have a higher risk of adverse outcomes after bariatric surgery.

JOURNAL OF CLINICAL SLEEP MEDICINE (2022)

Article Endocrinology & Metabolism

The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study

Cyrus Desouza, Ranee Chatterjee, Ellen M. Vickery, Jason Nelson, Karen C. Johnson, Sangeeta R. Kashyap, Michael R. Lewis, Karen Margolis, Richard Pratley, Neda Rasouli, Patricia R. Sheehan, Anastassios G. Pittas

Summary: The study investigated the effects of vitamin D supplementation on cardiovascular outcomes in adults with prediabetes, finding that it did not reduce Major Adverse Cardiovascular Events (MACE) but did have a small favorable effect on ASCVD risk score.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

Article Medicine, Research & Experimental

Effects of Metabolic Medicine and Metabolic Surgery on Patient-Reported Outcomes Among Patients with Type 2 Diabetes

Karim Kheniser, Ali Aminian, Sangeeta R. Kashyap

Summary: The assessment and management of patient-reported outcomes (PROs) is considered secondary to that of cardiometabolic outcomes. Health-related quality of life (HRQOL), a PRO, can provide information that can't be obtained from cardiometabolic assessments, such as quantifying and treating physical and mental distress, as well as evaluating treatment convenience and satisfaction.

METABOLIC SYNDROME AND RELATED DISORDERS (2022)

Article Endocrinology & Metabolism

Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice

Prabodh Sadana, Melissa Edler, Mirjavid Aghayev, Andrea Arias-Alvarado, Emilie Cohn, Serguei Ilchenko, Helen Piontkivska, Jagan A. Pillai, Sangeeta Kashyap, Takhar Kasumov

Summary: This study investigates the impact of gradual hyperglycemia during the progression of diabetes on HDL-associated protein dynamics in prediabetic and diabetic mice. The findings show that the fractional synthesis rate of HDL-associated proteins increases in prediabetic mice and decreases in diabetic mice compared to control mice. These kinetic changes provide insights into the mechanism of altered protein levels and HDL dysfunction during diabetes progression.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2022)

Article Endocrinology & Metabolism

Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes

Anira Iqbal, Zehra Tekin, Michael W. Kattan, Xinge Ji, Alex Milinovich, Kevin M. Pantalone, Robert S. Zimmerman, Mina K. Chung, Sangeeta Kashyap

Summary: Initiation of metformin as a first line monotherapy for T2D is not associated with a decreased risk of developing AF.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

Article Endocrinology & Metabolism

Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes

Michelle D. Lundholm, James Bena, Keren Zhou, Yumiko Tsushima, Sangeeta R. Kashyap

Summary: This study aimed to investigate the prevalence and clinical risk factors for non-alcoholic fatty liver disease (NAFLD) in type 1 diabetes (T1DM) using liver scores. The results showed that liver steatosis was common in adults with T1DM with obesity and/or metabolic syndrome, and was associated with older age, hypertension, and dyslipidemia. However, the diagnosis and treatment of NAFLD were still inadequate.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2023)

Editorial Material Endocrinology & Metabolism

Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes

Gwendolyne Anyanate Jack, Sangeeta R. Kashyap

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study*

Karen D. Corbin, Anastassios G. Pittas, Cyrus Desouza, Kristine K. Grdinovac, Karl-Heinz Herzig, Sangeeta R. Kashyap, Sun H. Kim, Jason Nelson, Neda Rasouli, Ellen M. Vickery, William C. Knowler, Richard E. Pratley

Summary: NAFLD is common in individuals at high risk for developing T2D and is associated with worse glycemic control. Routine screening for NAFLD using non-invasive scores may help reduce the burden of T2D and identify individuals who require further follow up to assess liver health.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2023)

Article Clinical Neurology

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease

Jagan A. Pillai, James Bena, Lynn Bekris, Nandan Kodur, Takhar B. Kasumov, James B. R. Leverenz, Sangeeta R. Kashyap

Summary: The relationship between biomarkers of metabolic syndrome and cognitive decline in individuals with mild cognitive impairment (MCI) and dementia stages of Alzheimer's disease (AD) was investigated. Elevated plasma triglyceride/HDL cholesterol (TG/HDL-C) ratio and plasma Apolipoprotein A1 (ApoA1) levels were associated with worse cognitive outcomes in MCI and dementia participants. However, CSF ApoA1 levels were found to relate to slower cognitive decline in MCI.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Cardiac & Cardiovascular Systems

Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort

Sangeeta R. Kashyap, Cyrus Desouza, Vanita R. Aroda, Sun H. Kim, Lisa M. Neff, Shannon S. Wu, Philip Raskin, Richard Pratley

Summary: This study analyzed the association between glycemic and metabolic sub-classifications of prediabetes and cardiovascular disease (CVD) risk, finding that multiple glycemic and metabolic criteria are needed to fully recognize the elevated CVD risk profile in prediabetes.

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

暂无数据